R. Lewis Dark

Articles by R. Lewis Dark

Two Major, Disruptive Changes Coming to Labs

TWO MAJOR, DISRUPTIVE CHANGES lie ahead for both clinical laboratories and anatomic pathology group practices. Each disruptive factor has nothing to do with how payers select in-network labs or reimburse for lab testing services.

Rather, one of these two major changes involves fundamental advances in the diagnostic technologies used by labs to diagnose disease and guide

Read More

Pulling Aside the Curtain on Alleged Lab Fraud

IN RECENT YEARS, MANY CLINICAL LAB ADMINISTRATORS AND PATHOLOGISTS have looked with dismay at the increased fraud associated with the laboratory test referrals of office-based physicians. High-profile federal cases involving lab companies accused of fraud garner national headlines.

Small companies sending sales reps into physicians’ offices, however, have changed the landscape in 2018 versus that of

Read More

Is the Worm Turning in Favor of Hospital Labs?

SINCE THE MID-1990S, HOSPITAL OUTREACH LABORATORY PROGRAMS have lost market share steadily to the nation’s biggest public lab companies. In these two decades, public lab companies traded deeply-discounted lab test prices to health insurers in exchange for exclusive network provider status.

Then, about eight years ago, having captured many managed-care contracts across the nation, big lab

Read More

To Add Value, Focus on Patient Care

FOR THE PAST SEVERAL YEARS, and particularly since Congress passed the Patient Access to Medicare Act in 2014, clinical labs have focused on controlling costs, as they should. After all, PAMA calls for steep cuts in what the federal Centers for Medicare and Medicaid Services will pay clinical labs beginning Jan. 1, 2018. (See TDRs,

Read More